China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$3.01 +0.20 (+7.12%)
At close: Sep 30, 2026 · 4:00 PM EDT

China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020)

Updated

China SXT Pharmaceuticals' Current Deferred Tax Assets was $50,000 in fiscal Q4 2020 (quarter ended Mar 31, 2020).

Analysis

China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 China SXT Pharmaceuticals 39,500.23 -85.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 50,000.00
API Access

China SXT Pharmaceuticals Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=SXTC&period=max&api_key=YOUR_API_KEY